v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) - USD ($)
Preferred Stock
Common Stock
Common Stock Issuable
Additional Paid-in capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 790 $ 3,033,013 $ (4,391,924) $ (1,358,121)
Balance (in Shares) at Dec. 31, 2024 790,385      
Net loss   (402,397) (402,397)
Balance at Mar. 31, 2025 $ 790 3,033,013 (4,794,321) (1,760,518)
Balance (in Shares) at Mar. 31, 2025 790,385      
Balance at Dec. 31, 2024 $ 790 3,033,013 (4,391,924) (1,358,121)
Balance (in Shares) at Dec. 31, 2024 790,385      
Net loss           (3,064,590)
Balance at Jun. 30, 2025 $ 1,258 17,192,935 (7,456,514) 9,737,679
Balance (in Shares) at Jun. 30, 2025 1,257,598      
Balance at Mar. 31, 2025 $ 790 3,033,013 (4,794,321) (1,760,518)
Balance (in Shares) at Mar. 31, 2025 790,385      
Net loss (2,662,193) (2,662,193)
Stock-based compensation 192,053 192,053
Common stock grants (CEO, CMO) $ 100 1,699,900 1,700,000
Common stock grants (CEO, CMO) (in Shares) 100,000      
Conversion of convertible debt $ 30 499,192 499,222
Conversion of convertible debt (in Shares) 29,713      
IPO representative warrants 139,388 139,388
IPO common stock issuance, net $ 338 11,629,389 11,629,727
IPO common stock issuance, net (in Shares) 337,500      
Balance at Jun. 30, 2025 $ 1,258 17,192,935 (7,456,514) 9,737,679
Balance (in Shares) at Jun. 30, 2025 1,257,598      
Balance at Dec. 31, 2025 $ 748 $ 1,258 163,738,882 (10,393,061) 153,347,827
Balance (in Shares) at Dec. 31, 2025 747,702 1,257,598      
Net loss (35,059,852) (35,059,852)
Issuance of common stock under advisory agreement (May 11, 2026) $ 8,113,318 8,113,318
Issuance of common stock under advisory agreement (May 11, 2026) (in Shares) 455,804      
Stock-based compensation 114,166 114,166
Balance at Mar. 31, 2026 $ 748 $ 1,258 $ 8,113,318 163,853,048 (45,452,913) 126,515,459
Balance (in Shares) at Mar. 31, 2026 747,702 1,257,598 455,804      
Balance at Dec. 31, 2025 $ 748 $ 1,258 163,738,882 (10,393,061) 153,347,827
Balance (in Shares) at Dec. 31, 2025 747,702 1,257,598      
Net loss           (55,232,982)
Balance at Jun. 30, 2026 $ 748 $ 1,509 $ 3,636,262 168,436,065 (65,626,043) 106,448,541
Balance (in Shares) at Jun. 30, 2026 747,702 1,509,118 204,284      
Balance at Mar. 31, 2026 $ 748 $ 1,258 $ 8,113,318 163,853,048 (45,452,913) 126,515,459
Balance (in Shares) at Mar. 31, 2026 747,702 1,257,598 455,804      
Net loss   (20,173,129) (20,173,129)
Issuance of common stock under advisory agreement (May 11, 2026) $ 251 $ (4,477,056) 4,476,805
Issuance of common stock under advisory agreement (May 11, 2026) (in Shares) 251,520 (251,520)      
Stock-based compensation 105,210 105,210
Subscription receivable collected on subsidiary shares 1,002 1,002
Balance at Jun. 30, 2026 $ 748 $ 1,509 $ 3,636,262 $ 168,436,065 $ (65,626,043) $ 106,448,541
Balance (in Shares) at Jun. 30, 2026 747,702 1,509,118 204,284